• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

c-LEcta

edit

c-LEcta is a White Biotechnology company dealing with the industrial use of biological processes

Focussed on the utilization of proteins with catalytic properties, more commonly refereed to as enzymes. Based on patented technologies c-LEcta is specialized in the discovery, optimization and production of high-value enzymes.

The company covers the complete value chain up to the enzyme application and is a one-stop provider of tailor made enzymatic solutions. The technological leadership and the internal expertise of the company provide an efficient and quality-oriented project handling throughout.

Recent Milestones

edit

• 
  c-LEcta received () in Series C funding. (4/8/08)
  Posted 5/26/09 at 5:06am
• 
  c-LEcta received $726k in Venture Round funding. (1/20/06)
  Posted 5/2/10 at 7:05pm
• 
  c-LEcta added Marc Struhalla as MD.
  Posted 5/26/09 at 5:01am
• 
  c-LEcta added Thomas Greiner-Stöffele as CSO.
  Posted 5/26/09 at 5:01am
• 
  c-LEcta added Carsten Fietz as CFO.
  Posted 5/26/09 at 5:01am

Videos

Screenshots

edit

Above: Homepage
Uploaded: 5/26/09

Sources

1. EDGAR [edit]
2. Capital Funding Report [edit]